OVID - Ovid Therapeutics reports Q3 results
2023-11-03 10:19:14 ET
More on Ovid Therapeutics
- Ovid Therapeutics: The GABA Gambit In Seizure Wars
- Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M
- Seeking Alpha’s Quant Rating on Ovid Therapeutics
- Historical earnings data for Ovid Therapeutics
- Financial information for Ovid Therapeutics
For further details see:
Ovid Therapeutics reports Q3 results